ABSTRACT Airway responsiveness to inhaled methacholine and to ultrasonically nebulised hyperosmolar saline was compared in 20 asthmatic subjects. Each subject had two hyperosmolar inhalation tests and a methacholine challenge in random order at least 48 hours apart over a period oftwo weeks. Hyperosmolar challenge, carried out with doubling concentrations of saline from 0-9% to 14-4% to obtain a dose-response curve, was well tolerated by all subjects. The response to hyperosmolar saline-expressed as the P020, the osmolarity inducing a 20% fall in forced expiratory volume in one second (FEV,) was obtained in 16 of the 20 subjects and in each was repeatable to within one doubling concentration of saline. The peak bronchoconstrictor effect of hyperosmolar saline inhalation occurred at 3 minutes and its mean total duration (FEV, < 90% of baseline) was 50 minutes. There was no significant correlation between the P020 and the PC20 methacholine (the concentration inducing a 20% fall in FEV,). Thus by using a new method to obtain a quantitative airway response to inhaled hyperosmolar saline we found that the airway response to hyperosmolar inhalation differs from the airway response to methacholine.
The inhalation of hyposmolar or hyperosmolar solutions may induce bronchoconstriction in asthmatic subjects' and provides a new method to investigate non-specific bronchial responsiveness. It has been suggested that this type of bronchial provocation test may be useful in the diagnosis and evaluation of asthma4 and for studying the mechanisms of exercise induced asthma.56 The hyperosmolar inhalation test, however, has not been standardised and little is known about the mechanisms by which it induces bronchoconstriction.
Findlay and colleagues have shown that hyperosmolar stimulation can induce the release of histamine from human basophils.7 Both hypo-osmolar and hyperosmolar solutions of glucose and saline produced bronchoconstriction in patients with mild asthma, whereas an ion free iso-osmolar solution did not reduce expiratory flow rate.8 Pretreatment with nebulised sodium cromoglycate reduced the response to 3-6% saline, suggesting that chemical mediators may be released from mast cells in response to hyperosmolar challenge.'
There have been reports of some degree of correlation between the airway responses to different nonspecific stimuli, such as exercise and inhaled histamine,9 isocapnic hyperventilation of cold air and inhaled methacholine or ultrasonically nebulised water,'0" and the inhalation of distilled water and exercise.'2 Little, however, is known about the relationship between the bronchial response to hyperosmolar solutions and other bronchoconstrictor stimuli.
This study was designed to develop a method to measure non-specific bronchial reactivity to hyperosmolar solutions in a dose-response manner, to verify its reproducibility, to examine tolerance to high concentrations of saline, and to compare the airway response to hyperosmolarity with the response to inhaled methacholine in the same subjects.
Methods
Twenty patients with asthma as defined by the American Thoracic Society (10 of them women), aged 17-48 years, took part to the study ( symptoms were controlled by an inhaled fi2 agonist as
The initial evaluation included measurement of required; five subjects were taking theophylline and FEV, and forced vital capacity (FVC) with the four ipratropium bromide. Patients with a past history vitalograph spirometer (S model) and of bronchial of cardiovascular disease, recent unstable asthma, or responsiveness to methacholine, by the method desrespiratory infection in the last month were excluded cribed by Cockcroft et al. On the three subsequent from the study. No subject was currently exposed to an visits a methacholine inhalation test and two hyperosantigen to which he was known to be sensitised. The molar challenges were performed in a randomised, study was approved by the hospital ethics committee double blind order. After each test subjects were asked and all subjects signed a consent form. to record the occurrence of respiratory symptoms. To determine the time course of hyperosmolar induced bronchoconstriction, FEV, was measured every two minutes for the first 15 minutes after the last inhalation of hyperosmolar saline and then every five minutes for one hour. If symptoms persisted after one hour, 200 pg inhaled salbutamol was administered., The peak action was defined as the maximum fall in FEVY obtained after the last inhalation of hyperosmolar saline, and the plateau as the time the FEV, remained within 10% of the peak value. The mean recovery time was the interval between the peak action and return of the FEVY to within 90% of baseline.
STATISTICAL ANALYSIS
All analyses were carried out on logarithmically transformed PO20 and PC20 values. Differences between the two PG20 saline and the two PC20 methacholine values were analysed with paired t tests. The differences between the results of the two hyperosmolar challenges were plotted against their mean value to assess the repeatability of the tests.'5 To determine whether PC20 methacholine was correlated with PO20
saline a linear regression analysis was performed.
Results
All 20 subjects studied completed the study. The responses to the challenges are summarised in table 2. The side effects of hyperosmolar saline were similar to those of methacholine-transient cough, hypersecretion, and mild dyspnoea. After the study no increase in asthma symptoms or need to increase medication was reported apart from some continuing hypersecretion for a few hours after the osmolar challenge. Serum sodium concentrations, measured in four subjects after 10 minutes' inhalation of 14-4% saline, were unchanged.
A PO,0 saline value was obtained in 16 of the 20 subjects; in the other four even the highest concentration (14.4%) did not induce a fall in FEVY. Figure I shows the relation between the PO20 values from the two hyperosmolar tests. The difference in geometric mean PO20 values was not significant (p > 0 05 Our results confirm the findings of previous studies showing that inhalation of hyperosmolar solution causes bronchoconstriction in asthmatic subjects.381
There was no correlation between the response to hyperosmolar solution and the response to methacholine. The hyperosmolar stimulus thus appears to differ from the other non-specific stimuli such as cold air, exercise, PGF2,, histamine, and methacholine since these have been shown to be correlated.90' 9
The response to methacholine and histamine has been shown to be related to the severity of asthma and the amount of medication required to control symptoms.0 This does not seem to be the case with hyperosmolar solutions, since there was no correlation between the PO20 and the severity of asthma, as assessed by baseline expiratory flow rates, medication needed to control asthma, or the PC20 methacholine. This suggests that the mechanism underlying the response to hyperosmolar solutions is different in the asthmatic population.
One of the main hypotheses to explain exercise induced asthma is that airway secretions become hyperosmolar during hyperventilation. 6 We are therefore investigating the bronchial response to hyperosmolar saline and exercise. A correlation between the bronchial response to inhalation of hypoosmolar solution and exercise has been reported. '2 Further studies are required to determine the consequences ofairway dehydration in different situations and the role of mediators of inflammation in the development of bronchoconstriction induced by this stimulus.
In conclusion, we describe a new method of bronchoprovocation with hyperosmolar saline. This method is simple, reproducible, and safe. There was no correlation between the bronchial response to hyperosmolarity and the response to methacholine. This test may be of limited usefulness in the evaluation of non-specific bronchial reactivity or the degree of severity of asthma, but is an interesting tool to study the effect of osmolar changes in the airways, particularly in relation to exercise induced asthma. 
